331 related articles for article (PubMed ID: 8190112)
1. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
Olah ME; Gallo-Rodriguez C; Jacobson KA; Stiles GL
Mol Pharmacol; 1994 May; 45(5):978-82. PubMed ID: 8190112
[TBL] [Abstract][Full Text] [Related]
2. [125I]4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I)AB-MECA) labels multiple adenosine receptor subtypes in rat brain.
Shearman LP; Weaver DR
Brain Res; 1997 Jan; 745(1-2):10-20. PubMed ID: 9037389
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou QY; Li C; Olah ME; Johnson RA; Stiles GL; Civelli O
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7432-6. PubMed ID: 1323836
[TBL] [Abstract][Full Text] [Related]
4. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor.
Auchampach JA; Jin X; Wan TC; Caughey GH; Linden J
Mol Pharmacol; 1997 Nov; 52(5):846-60. PubMed ID: 9351976
[TBL] [Abstract][Full Text] [Related]
5. A selective agonist affinity label for A3 adenosine receptors.
Ji XD; Gallo-Rodriguez C; Jacobson KA
Biochem Biophys Res Commun; 1994 Aug; 203(1):570-6. PubMed ID: 8074705
[TBL] [Abstract][Full Text] [Related]
6. 125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.
Palmer TM; Poucher SM; Jacobson KA; Stiles GL
Mol Pharmacol; 1995 Dec; 48(6):970-4. PubMed ID: 8848012
[TBL] [Abstract][Full Text] [Related]
7. Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors.
Hill RJ; Oleynek JJ; Hoth CF; Kiron MA; Weng W; Wester RT; Tracey WR; Knight DR; Buchholz RA; Kennedy SP
J Pharmacol Exp Ther; 1997 Jan; 280(1):122-8. PubMed ID: 8996189
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.
Ramkumar V; Barrington WW; Jacobson KA; Stiles GL
Mol Pharmacol; 1990 Feb; 37(2):149-56. PubMed ID: 2304450
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of the human A3 adenosine receptor.
Salvatore CA; Jacobson MA; Taylor HE; Linden J; Johnson RG
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10365-9. PubMed ID: 8234299
[TBL] [Abstract][Full Text] [Related]
11. Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptors.
Yates L; Clark JH; Martin TJ; James S; Broadley KJ; Kidd EJ
Auton Autacoid Pharmacol; 2006 Apr; 26(2):191-200. PubMed ID: 16553647
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
13. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
14. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.
Ramkumar V; Stiles GL; Beaven MA; Ali H
J Biol Chem; 1993 Aug; 268(23):16887-90. PubMed ID: 8349579
[TBL] [Abstract][Full Text] [Related]
15. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
Klotz KN; Camaioni E; Volpini R; Kachler S; Vittori S; Cristalli G
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):103-8. PubMed ID: 10494877
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A
J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
Linden J; Thai T; Figler H; Jin X; Robeva AS
Mol Pharmacol; 1999 Oct; 56(4):705-13. PubMed ID: 10496952
[TBL] [Abstract][Full Text] [Related]
18. Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.
van Rhee AM; Jiang JL; Melman N; Olah ME; Stiles GL; Jacobson KA
J Med Chem; 1996 Jul; 39(15):2980-9. PubMed ID: 8709132
[TBL] [Abstract][Full Text] [Related]
19. Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives.
Gao ZG; Kim SG; Soltysiak KA; Melman N; IJzerman AP; Jacobson KA
Mol Pharmacol; 2002 Jul; 62(1):81-9. PubMed ID: 12065758
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.
Jacobson KA; Siddiqi SM; Olah ME; Ji XD; Melman N; Bellamkonda K; Meshulam Y; Stiles GL; Kim HO
J Med Chem; 1995 May; 38(10):1720-35. PubMed ID: 7752196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
